Patient assistance programs (PAPs) are programs created by drug companies,
such as NOVARTIS PHARMACEUTICALS CORPORATION, to offer free or low cost drugs to individuals who are unable to
pay for their medication. These Programs may also be called indigent drug programs,
charitable drug programs or medication assistance programs. Most of the best known and
most prescribed drugs can be found in these programs. All of the major drug companies
have patient assistance programs, although every company has different eligibility and
application requirements.
The NOVARTIS PHARMACEUTICALS CORPORATION patient assistance program offers free medication to people
who otherwise cannot afford their medications. Patients must meet financial and other
program specific criteria to be eligible for assistance.
For a complete listing of NOVARTIS PHARMACEUTICALS CORPORATION medications available through
their patient assistance programs, see below:
Alongside KESIMPTA Program
|
| |
The medications available through this program are:
|
| |
| Kesimpta injection
(ofatumumab) |
|
|
|
Leqvio Service Center and Care Program
|
| |
The medications available through this program are:
|
| |
| Leqvio
(inclisiran injection) |
|
|
|
Novartis Patient Assistance Foundation, Inc.
|
| |
The medications available through this program are:
|
| |
| Adakveo
(crizanlizumab-tmca) |
|
| |
|
| |
| Afinitor Disperz
(everolimus) |
|
| |
| Beovu
(brolucizumab-dbll) |
|
| |
| Coartem
(artmether and lumefantrine tablets) |
|
| |
|
| |
| Entresto
(sacubitril/valsartan) |
|
| |
| Extavia
(interferon beta-1b) |
|
| |
|
| |
|
| |
| Jadenu Sprinkle granules
(deferasirox) |
|
| |
| Jadenu Tablet
(deferasirox) |
|
| |
| Kesimpta injection
(ofatumumab) |
|
| |
|
| |
| Kisqali Femara Co-Pack tablets
(ribociclib and letrozole) |
|
| |
| Leqvio
(inclisiran injection) |
|
| |
| Lutathera
(lutetium Lu 177 dotatate) |
|
| |
|
| |
|
| |
|
| |
|
| |
| Sandostatin LAR Depot
(octreotide acetate) |
|
| |
| Scemblix tablet
(asciminib tablet) |
|
| |
|
| |
|
| |
|
| |
| Tykerb
(lapatinib tablets) |
|
| |
|
| |
| Xiidra
(lifitegrast ophthalmic solution)) |
|
| |
|
| |
| betaxolol hydrochloride suspension
Betoptic S |
|
| |
| midostaurin capsule
Rydapt |
|
|
|
Novartis Patient Assistance Now Oncology (PANO)
|
| |
The medications available through this program are:
|
| |
| Adakveo
(crizanlizumab-tmca) |
|
| |
|
| |
|
| |
|
| |
| Gleevec
(imatinib mesylate) |
|
| |
|
| |
| Jadenu Tablet
(deferasirox) |
|
| |
|
| |
|
| |
|
| |
|
| |
| Rydapt
(midostaurin capsule) |
|
| |
| Sandostatin LAR Depot
(octreotide acetate) |
|
| |
|
| |
|
| |
|
| |
| Tykerb
(lapatinib tablets) |
|
| |
|
| |
|
| |
|
|
|
Universal Co-Pay Card
|
| |
The medications available through this program are:
|
| |
| Adakveo
(crizanlizumab-tmca) |
|
| |
|
| |
|
| |
| Gleevec
(imatinib mesylate) |
|
| |
| Jadenu Sprinkle granules
(deferasirox) |
|
| |
| Jadenu Tablet
(deferasirox) |
|
| |
|
| |
| Kisqali Femara Co-Pack tablets
(ribociclib and letrozole) |
|
| |
|
| |
|
| |
|
| |
| Rydapt
(midostaurin capsule) |
|
| |
| Sandostatin LAR Depot
(octreotide acetate) |
|
| |
| Scemblix tablet
(asciminib tablet) |
|
| |
|
| |
|
| |
|
| |
| Tykerb
(lapatinib tablets) |
|
| |
|
| |
|
| |
|
|
|
